Talaromyces marneffei (Segretain et al.) Samson et al.
商品貨號
B192767
Deposited As
Penicillium marneffei Segretain et al.
Strain Designations
302 BM
Application
Biomedical Research and Development Material
Emerging infectious disease research
Biosafety Level
2
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country.
Product Format
freeze-dried
Storage Conditions
Frozen: -80°C or colder Freeze-Dried: 2°C to 8°C Live Culture: See Propagation Section
Type Strain
no
Preceptrol®
no
Comments
sialic acid-dependent processes
Medium
ATCC® Medium 325: Malt extract agar (Blakeslee's formula)
ATCC® Medium 336: Potato dextrose agar (PDA)
ATCC® Medium 2003: Czapek yeast extract agar
Growth Conditions
Temperature: 24°C to 26°C
Atmosphere: Typical aerobic
Name of Depositor
N Vanittanakom
Special Collection
NCRR Contract
Chain of Custody
ATCC <-- N Vanittanakom <-- C. Khumwan
Isolation
Bone marrow from AIDS patient, Chiang Mai, Thialand
References
Hamilton AJ, et al. Recognition of fibronectin by Penicillium marneffei conidia via a sialic acid-dependent process and its relationship to the interaction between conidia and laminin. Infect. Immun. 67: 5200-5205, 1999. PubMed: 10496896
Lasker BA. Nucleotide sequence-based analysis for determining the molecular epidemiology of Penicillium marneffei. J Clin Microbiol 44: 3145-3153, 2006. PubMed: 16954240
